CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Shareholders’ equity 2016–2025
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) shareholders’ equity at each fiscal year-end, per SEC filings.
$3.2BFY2025 · since FY2016: $836.8M → $3.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.2B | -8.6% |
| FY2024 | $3.5B | -3.8% |
| FY2023 | $3.6B | +20.9% |
| FY2022 | $3.0B | +17.4% |
| FY2021 | $2.5B | +19.9% |
| FY2020 | $2.1B | +29.4% |
| FY2019 | $1.6B | +24.1% |
| FY2018 | $1.3B | +26.1% |
| FY2017 | $1.0B | +24.9% |
| FY2016 | $836.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice